10.16
price down icon2.87%   -0.30
pre-market  Pre-mercato:  10.79   0.63   +6.20%
loading
Precedente Chiudi:
$10.46
Aprire:
$10.31
Volume 24 ore:
248.53K
Relative Volume:
2.01
Capitalizzazione di mercato:
$446.93M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-21.42%
1M Prestazione:
-26.22%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$9.37
$10.31
Intervallo di 1 settimana:
Value
$9.37
$13.35
Portata 52W:
Value
$9.37
$24.90

Sionna Therapeutics Inc Stock (SION) Company Profile

Name
Nome
Sionna Therapeutics Inc
Name
Telefono
617-819-2020
Name
Indirizzo
21 HICKORY DRIVE, SUITE 500, WALTHAM
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SION's Discussions on Twitter

Confronta SION con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SION
Sionna Therapeutics Inc
10.16 446.93M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-04 Iniziato Guggenheim Buy
2025-03-04 Iniziato Stifel Buy
2025-03-04 Iniziato TD Cowen Buy

Sionna Therapeutics Inc Borsa (SION) Ultime notizie

pulisher
Mar 31, 2025

In 2025, biotech IPOs were supposed to bounce back. It hasn't happened yet. - The Business Journals

Mar 31, 2025
pulisher
Mar 28, 2025

Sionna Therapeutics (NASDAQ:SION) Trading Down 4.2%What's Next? - MarketBeat

Mar 28, 2025
pulisher
Mar 22, 2025

Sionna Therapeutics (NASDAQ:SION) Reaches New 1-Year Low on Disappointing Earnings - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Stifel maintains Buy rating on Sionna Therapeutics stock at $32 target - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

SEC Form 10-K filed by Sionna Therapeutics Inc. - Quantisnow

Mar 20, 2025
pulisher
Mar 20, 2025

Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

SIONSionna Therapeutics Latest Stock News & Market Updates - StockTitan

Mar 20, 2025
pulisher
Mar 17, 2025

Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews

Mar 17, 2025
pulisher
Mar 15, 2025

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Top 10 Insider Purchases Last Month - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Sionna Therapeutics, Inc.’s Quiet Period To Expire on March 19th (NASDAQ:SION) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

February financings slowing, but year outpaces 2022-2023 - BioWorld Online

Mar 11, 2025
pulisher
Mar 08, 2025

Guggenheim Initiates Coverage on Sionna Therapeutics (NASDAQ:SION) - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

Sionna Therapeutics (NASDAQ:SION) Earns Buy Rating from Analysts at TD Cowen - MarketBeat

Mar 07, 2025
pulisher
Mar 07, 2025

Investorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports - Investorideas.com newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 06, 2025
pulisher
Mar 06, 2025

Stifel Nicolaus Initiates Coverage on Sionna Therapeutics (NASDAQ:SION) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Sionna Therapeutics (NASDAQ:SION) Coverage Initiated at TD Cowen - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

Sionna Therapeutics (NASDAQ:SION) Now Covered by Stifel Nicolaus - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

TD Cowen Initiates Sionna Therapeutics at Buy -March 04, 2025 at 07:57 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target -March 04, 2025 at 07:58 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target -March 04, 2025 at 07:57 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

TD Cowen initiates Sionna Therapeutics stock with Buy rating By Investing.com - Investing.com UK

Mar 04, 2025
pulisher
Mar 04, 2025

Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Guggenheim sets Sionna stock Buy rating, $45 target By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 03, 2025

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey

Mar 03, 2025
pulisher
Feb 27, 2025

Sionna Therapeutics’ NBD1 stabilizers hold potential for cystic fibrosis - The Pharma Letter

Feb 27, 2025
pulisher
Feb 25, 2025

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market - Yahoo Finance

Feb 25, 2025
pulisher
Feb 24, 2025

Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Clinical-Stage CF Treatment Developer Disrupt a $10B+ Market? Key Presentation Coming - Stock Titan

Feb 24, 2025
pulisher
Feb 21, 2025

Sionna Therapeutics (SION) Surges in Nasdaq Debut Before Paring Gains - HPBL

Feb 21, 2025
pulisher
Feb 18, 2025

Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10 - Marketscreener.com

Feb 18, 2025
pulisher
Feb 17, 2025

The Surprising Stock Insiders Can’t Stop Buying: What’s the Hype? - MotoPaddock

Feb 17, 2025
pulisher
Feb 17, 2025

Sionna Therapeutics: The Biotech Stock Insiders Are Snapping Up! - Smartphone Magazine

Feb 17, 2025
pulisher
Feb 17, 2025

Sionna Therapeutics: The Under-the-Radar Insider Favorite You’ve Been Missing - Anexartiti

Feb 17, 2025
pulisher
Feb 17, 2025

Biopharma Gamble: Why Insiders Are Betting Big on Sionna Therapeutics - DSA

Feb 17, 2025
pulisher
Feb 17, 2025

Why Insiders Are Betting Big on Sionna Therapeutics This Year - Bit Perfect Solutions

Feb 17, 2025
pulisher
Feb 17, 2025

The Biopharma Gamble: Why Insiders Are Banking on Sionna Therapeutics - Elblog.pl

Feb 17, 2025
pulisher
Feb 17, 2025

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year? - Insider Monkey

Feb 17, 2025
pulisher
Feb 17, 2025

10 Stocks Insiders Are Buying This Year - Insider Monkey

Feb 17, 2025
pulisher
Feb 16, 2025

A Buffett Buy, a Biotech IPO, and Other Big Insider Buying - 24/7 Wall St.

Feb 16, 2025
pulisher
Feb 13, 2025

Sionna therapeutics sees $20.25 million stock purchase by TPG - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Sionna Therapeutics’ $219.2 Million Upsized IPO - Global Legal Chronicle

Feb 13, 2025
pulisher
Feb 12, 2025

Major Stock Acquisition Signals Confidence in Sionna Therapeutics - TipRanks

Feb 12, 2025

Sionna Therapeutics Inc Azioni (SION) Dati Finanziari

Non sono disponibili dati finanziari per Sionna Therapeutics Inc (SION). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):